[68 Ga]Ga-FAPI versus [18F]F-FDG in malignant melanoma: complementary or counterpoint?

Mokoala, Kgomotso M.G.; Emil, Novruzov; Lawal, Ismaheel Opeyemi; Antke, Christina; Giesel, Frederik L.; Sathekge, Mike Machaba

dc.contributor.author	Mokoala, Kgomotso M.G.
dc.contributor.author	Emil, Novruzov
dc.contributor.author	Lawal, Ismaheel Opeyemi
dc.contributor.author	Antke, Christina
dc.contributor.author	Giesel, Frederik L.
dc.contributor.author	Sathekge, Mike Machaba
dc.date.accessioned	2022-07-22T07:59:39Z
dc.date.issued	2022-06
dc.description.abstract	No abstract available.	en_US
dc.description.department	Nuclear Medicine	en_US
dc.description.embargo	2023-02-09
dc.description.librarian	dm2022	en_US
dc.description.uri	https://www.springer.com/journal/259	en_US
dc.identifier.citation	Mokoala, K., Emil, N., Lawal, I. et al. [68 Ga]Ga-FAPI versus [18F]F-FDG in malignant melanoma: complementary or counterpoint?. European Journal of Nuclear Medicine and Molecular Imaging 49, 2445–2446 (2022). https://doi.org/10.1007/s00259-022-05702-2.	en_US
dc.identifier.issn	1619-7070 (print)
dc.identifier.issn	1619-7089 (online)
dc.identifier.other	10.1007/s00259-022-05702-2
dc.identifier.uri	https://repository.up.ac.za/handle/2263/86394
dc.language.iso	en	en_US
dc.publisher	Springer	en_US
dc.rights	© The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022.	en_US
dc.subject	Fibroblast activation protein (FAP)	en_US
dc.subject	Malignant melanoma	en_US
dc.title	[68 Ga]Ga-FAPI versus [18F]F-FDG in malignant melanoma: complementary or counterpoint?	en_US
dc.type	Postprint Article	en_US